Synexus Poland celebrates success of first ‘Importance of Clinical Trials in Medical Practice’ conference

14 Dec 2009

Synexus in Poland organised the first ‘Importance of Clinical Trials in Medical Practice' conference last week, in conjunction with Wroclaw Medical University. The event, targeting senior medical professionals, aimed to raise awareness of the vital role of clinical research in drug development and the importance of the business to Poland.

Radoslaw Janiak M.D, who is Synexus Country Manager in Poland, was delighted not only with the high turn out for the event, but also with the level of interest amongst some of the leading medical academics and consultants who attended: "We had more than two hundred and fifty people join us for the conference, including Professor Ryszard Andrzejak, Dean of Wroclaw Medical University, Professor Anna Wiela-Hojenska, Dean of the Pharmacy Faculty at Wroclaw Medical University, and Professor Andrzej Czlonkowski, Chief of Clinical and Experimental Pharmacology Department, Warsaw Medical University. It is very encouraging to see these individuals, who are key to the further development of the clinical trials sector in Poland, taking the time to learn more about this area and the role they can play in its development. This is a real opportunity for Poland to be a world player."

Synexus has been operating in Poland since 2006 and expanded its operations there in August of this year when it acquired three new dedicated research centres in Warsaw, Gdynia and Katowice, following its takeover of CLCC.

The European clinical trials market was worth an estimated €20.3 billion in 2008 with annual growth of 10.6% forecast until 2012 giving a value of €30.38 billion. The most significant growth is expected to come from the Central and Eastern European countries, including Poland.

Synexus has expanded its operations in Central and Eastern Europe to 16 dedicated research centres across Poland, Hungary, Bulgaria and Ukraine, and is working hard to raise the profile of the clinical trials sector with medical and academic bodies, to secure not only their future involvement, but also to drive sustained and competitive growth in the region. Synexus has changed the traditional model for carrying out clinical trials from individual sites, often with only one investigator, to its own dedicated research centres, staffed by full-time, professional investigators, focussing solely on the recruitment and running of clinical trials.

Back to top ^

Synexus Limited, Registered in England and Wales, Registered number 3724238, Registered Office: Sandringham House, Ackhurst Park, Chorley , Lancashire, PR7 1NY

Strength in numbers

Synexus Poland celebrates success of first ‘Importance of Clinical Trials in Medical Practice’ conference

Regulatory

Patient

Therapy